Holly London

Holly London (Haase) PhD is a seasoned professional in the pharmaceutical industry, currently serving as the Head of Strategic Realization at BioMarin Pharmaceutical Inc. since January 2014, where responsibilities include facilitating planning and execution of Technical Operations' goals, managing communication across functions, and leading special projects. Holly's previous roles at BioMarin include Senior Director of TOPS Product Technical Strategy and CMC Lead, emphasizing quality strategy and cross-functional initiatives. Prior to BioMarin, Holly worked at Novartis Vaccines and Diagnostics as a Purification Scientist and at Affymax as a Staff Scientist. Academic credentials include a PhD in Organic Chemistry/Chemical Biology from the University of Wisconsin-Madison and a B.S. in Chemistry from Santa Clara University. Holly's doctoral research focused on developing peptide inhibitors targeting protein-protein interactions.